Answers are grounded in this paper and cite their sources.
Benefits and harms vary among atypical antipsychotic medications for off-label use. For global behavioral symptom scores associated with dementia in elderly patients, small but statistically significant benefits were observed for aripiprazole, olanzapine, and risperidone. Quetiapine was associated with benefits in the treatment of generalized anxiety disorder, and risperidone was associated with benefits in the treatment of obsessive-compulsive disorder; however, adverse events were common.
No takes yet. Share an insight, caveat, or question.
Maher et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: